Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Pink

KLYGKelyniam Global, Inc.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About Kelyniam Global, Inc. (KLYG)

Kelyniam Global, Inc. (KLYG) is a Medical Devices company headquartered in Canton, CT, United States whose shares trade over-the-counter on the Pink tier.

Kelyniam is a Medical Device Manufacturing company that specializes in the production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced polymers. The company's Engineering division is constantly working with medical professionals by allowing them to operate more effectively, improving patient care, and reducing health care cost by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.

Products and services

Kelyniam Global, Inc. is a medical device manufacturing company. The Company is engaged in the production of custom cranial prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient's computed tomography (CT) scan data, the Company's 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge.

KLYG key facts

Ticker symbol
KLYG
Market tier
Pink
Headquarters
Canton, CT, United States
Country of incorporation
US
Year of incorporation
2005
Employees
9
Estimated market cap
$8.95M (as of Apr 16, 2025)
Shares outstanding
49,718,430
Reporting standard
Alternative Reporting Standard
Audit status
Unaudited
Fiscal year end
12/31
Latest filing
Annual Report (Dec 31, 2024)

Kelyniam Global, Inc. leadership

  • Ross Bjella — CEO
  • Terrance Kurtenbach — CFO
  • Desiree Webb — EVP, Ops.
  • Ki Xiong — Chief Accounting Officer

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with K

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for Kelyniam Global, Inc. (KLYG) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Investor Relations Email
Not provided
Headquarters Address
97 River Road
Canton, CT, 06019
United States

Company Leadership

Chief Executive Officer

C
CEO Information Not Available
Chief Executive Officer

Company Officers

Ross Bjella
CEO
Terrance Kurtenbach
CFO
Desiree Webb
EVP, Ops.
Ki Xiong
Chief Accounting Officer

Social Media

Business Details

Stock Details

Loading modules...